pan-KRASmt AOC (GeneQuantum)

N/A

Report date: 2026/04/15 20:02:38

Base Information

Drug Namepan-KRASmt AOC (GeneQuantum)

Drug Alias NameN/A

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Monoclonal antibody conjugate > Antibody-Oligonucleotide conjugate > Antibody-siRNA conjugate

Mechanisms of ActionV-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog inhibitors

TargetsGTPase KRas

Therapy Area/IndicationsPancreatic NeoplasmsAdenocarcinoma of Lung

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaPreclinical

Originator CompaniesGeneQuantum Healthcare (Suzhou) Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesGeneQuantum Healthcare (Suzhou) Co Ltd

Inactive CompaniesN/A

Active IndicationsPancreatic NeoplasmsAdenocarcinoma of Lung

Inactive IndicationsN/A

Other Information

ATC CodeN/A